Efficacy of peripheral targeted inhaled rhDNase [dornase-alfa] for persistent obstructive asthma in childhood.

Trial Profile

Efficacy of peripheral targeted inhaled rhDNase [dornase-alfa] for persistent obstructive asthma in childhood.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Dec 2011

At a glance

  • Drugs Dornase alfa (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms IDOL
  • Most Recent Events

    • 13 Jan 2011 Last checked Netherlands Trial Register record.
    • 04 Jul 2010 New source identified and integrated (Netherlands Trial Register record NTR671).
    • 08 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top